Expression of CEBPD and SOCS2 was consistently upregulated in NAFLD clinical datasets, FFA-treated HepG2 cells, and liver tissues of HFD-induced NAFLD mice, but not in AIS datasets or OGD-treated microglial cells. The gene discussed is CEBPD; the disease is metabolic dysfunction-associated steatotic liver disease.